Uno de mis pacientes, un veterano que haba intentado dejar de fumar durante ms de una dcada, me cont que despus de empezar a tomar un frmaco GLP-1 para su diabetes perdi el inters por los cigarrillos
Recent evidence highlights GLP-1RAs as a promising adjunctive therapy in critical conditions due to their protective effects: they improve endothelial function, reduce ischemiareperfusion injury, and regulate autonomic tone in the cardiovascular system
For the study, which was published in the journal Molecular and Cellular Neuroscience , researchers reviewed findings from 30 preclinical studiesmostly on animals and cellsthat looked at the impact on signs of Alzheimers disease of four GLP-1 receptor agonists: liraglutide (Victoza, Saxenda), semaglutide (Ozempic, Wegovy), exenatide (Byetta), and dulaglutide (Trulicity)
HDACs silence genes by stripping away acetyl groups from histones
doi:10.1016/0014-5793(95)01070-U